Executive Summary
In a landmark transition for international development policy, the United States government (USG) has fundamentally restructured its approach to global health assistance. Under the "America First Global Health Strategy," released on September 18, 2025, the U.S. is moving away from perpetual aid cycles toward a framework defined by bilateral Memorandums of Understanding (MOUs). These five-year agreements (2026–2030) signal a paradigm shift: as the U.S. incrementally scales back its financial contributions, partner nations are mandated to increase their own domestic "co-investment" in health.
As of September 2026, 34 countries have entered into these agreements. While the stated goal is to foster "resilient and durable health systems" through local ownership, the fiscal reality is significant: an analysis of the agreements signed to date indicates a projected $7.3 billion reduction in U.S. global health assistance, a 34% decrease compared to historical funding levels.
Chronology: A New Era for Foreign Assistance
The transition to the "America First" model did not happen overnight, but rather through a carefully sequenced policy rollout.
- January 13, 2026: Initial policy resources and frameworks were published, signaling the upcoming pivot in diplomatic and health outreach.
- September 18, 2025: The official release of the "America First Global Health Strategy" document. This report codified the expectation that U.S. assistance should no longer be a permanent fixture, but a catalyst for national health system maturity.
- Late 2025 – Early 2026: The U.S. Department of State and USAID began aggressive bilateral negotiations. The goal was to secure MOUs before the start of the 2026 fiscal cycle.
- July 1, 2026: The primary data cutoff for the current assessment of the 34 signed agreements.
- September 11, 2026: A major update to the tracking framework, incorporating emerging data on co-financing shares and program implementation challenges.
The implementation phase is currently in its nascent stages, with countries now transitioning from the negotiation table to the operational phase of these five-year plans.
The Mechanics of the MOU Framework
The core of the new strategy rests on the principle of "co-investment." Unlike traditional grants, where the U.S. functioned as the primary financier for specific disease-control programs (such as HIV/AIDS or malaria), the MOUs act as a contract for gradual handover.
The Co-Investment Mandate
Partner nations are required to commit to a sliding scale of funding. As the U.S. contribution decreases on a predefined glide path, the partner country’s ministry of health must fill the budgetary gap. The theory of change is that this "skin in the game" forces governments to prioritize health in their national budgets, thereby making systems less vulnerable to the fluctuations of U.S. congressional appropriations.
Exceptions and Variations
Not all agreements are uniform. The U.S. has shown flexibility in specific contexts:
- Duration Adjustments: Countries such as Bolivia, Botswana, and Panama have negotiated three-year agreements rather than the standard five-year term, likely reflecting unique domestic economic conditions or political instability.
- Strategic Objective Agreements: The Philippines represents a unique case. Rather than signing a standard MOU, the country signed a "Strategic Objective Agreement." While it mirrors the spirit of the U.S. strategy, it offers more flexibility in how funding is classified, though the lack of public data on their co-financing targets makes them a notable outlier in current transparency reporting.
Supporting Data: A Fiscal Contraction
The most striking revelation from the current tracking data is the sheer scale of the funding reduction. An analysis of the 34 signed MOUs reveals a $7.3 billion decline in projected U.S. health spending over the next five years.
Funding Analysis
- Aggregate Change: -34%
- Contextualizing the Gap: Historical funding totals were calculated based on appropriated and planned amounts for FY21–23, combined with requested amounts for FY24–25. The shift represents a move from "assistance-dependent" models to "partner-led" models.
- Data Challenges: For many countries, the lack of granular data on domestic co-investment makes it difficult to verify whether national budgets are actually rising to meet the deficit left by the U.S. withdrawal. In the cases of Bolivia and Panama, there is insufficient historical data to even perform a reliable comparison against previous funding levels.
Programmatic Focus
The agreements are not merely about money; they are about programmatic priorities. Keyword analysis of the signed MOUs suggests a heavy focus on "Global Health Security" (GHS). This encompasses outbreak preparedness, laboratory strengthening, and surveillance capacity. The U.S. appears to be prioritizing its own domestic safety by ensuring that partner nations can identify and contain pathogens locally before they cross borders.
Official Perspectives and Diplomatic Stance
The U.S. Government Stance
The U.S. Department of State maintains that the strategy is a necessary maturation of international development. By "weaning" countries off foreign aid, the USG argues it is preventing the "aid dependency trap." Officials emphasize that the sustainability of a health system cannot be outsourced; it must be built on the tax base of the host nation.
Partner Country Reactions
Reactions from partner countries have been mixed. In some regions, ministries of health have welcomed the increased autonomy, viewing the MOUs as a way to align U.S. funding with their own National Health Plans. However, in low-resource settings, there is palpable anxiety. Public health experts in affected regions have expressed concern that the "co-investment" requirement is overly optimistic, fearing that the economic reality of these nations will not allow them to bridge the $7.3 billion gap, potentially leading to service disruptions in HIV treatment, vaccination programs, and maternal health care.
Implications for Global Health
The "America First" transition poses three fundamental risks and opportunities for the global health landscape:
1. The Risk of Service Fragmentation
If a partner nation fails to meet its co-investment targets, the automatic reduction in U.S. funding could result in a "cliff effect." Essential services, particularly those supporting marginalized populations, are at risk of being defunded if national governments prioritize debt servicing or other infrastructure over public health.
2. The Opportunity for Sovereignty
Proponents of the strategy argue that it forces a long-overdue conversation about local ownership. By removing the "shadow of the donor," local health officials are compelled to develop indigenous solutions, negotiate domestic drug pricing, and integrate health into the broader national economic strategy.
3. The Transparency Gap
A significant challenge remains in the reporting of these agreements. As the tracker highlights, official MOU documents are only publicly available for a minority of signatories. The reliance on press releases from embassies and ministries often results in "sanitized" data that masks the underlying fiscal tensions. Moving forward, the global health community must demand greater transparency in the reporting of co-financing targets to ensure that the "transition to ownership" is not merely a euphemism for a withdrawal of support.
Conclusion: A High-Stakes Experiment
The U.S. Global Health Strategy (2026–2030) is arguably the most significant shift in foreign aid policy in the 21st century. By prioritizing national self-reliance over consistent financial support, the U.S. is betting that local capacity will rise to meet the challenge.
However, the $7.3 billion reduction is a substantial figure that will define the quality and accessibility of healthcare for millions. Whether this strategy creates a new era of robust, independent health systems or leads to a period of instability and service decline will depend on the commitment of both the U.S. to flexible, evidence-based oversight and the partner nations to genuine fiscal reform. As this tracker continues to be updated, the international community must closely monitor the impact of these agreements, ensuring that the goal of "resilient systems" remains the primary metric of success, rather than just the reduction of the U.S. budget deficit.
Methodological Note: This analysis is based on a synthesis of U.S. Department of State disclosures, embassy press releases, and available MOU texts. All financial figures represent U.S. funding allocations only and do not account for external aid from non-U.S. donors or private foundations. Further updates will be provided as more MOU texts are declassified and released.
About the Author
